Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine as Sedative Agent in ERCP
NCT04490031Phase 4Recruiting
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Mar 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in endoscopic retrograde cholangiopancreatography (ERCP), sponsored by Hospital Canselor Tuanku Muhriz. Started Mar 2020; status: recruiting.
02
Drugs
ketamine
03
Conditions
endoscopic retrograde cholangiopancreatography (ERCP)
Beyond the preview
Go deeper on NCT04490031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04490031.